2025-03-29 13:18:17
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
Rossari Biotech Q3FY22 consolidated PAT at Rs. 22.53 crores
Posted On : 2022-02-16 18:08:39( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 434.772 crores during the period ended December 31, 2021 as compared to Rs. 388.478 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 22.539 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 26.229 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 4.07 for the period ended December 31, 2021 as compared to Rs. 4.74 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 434.772 crs | ₹388.478 crs |  11.92% |
| Net Profit | ₹22.539 crs | ₹26.229 crs |  -14.07% |
| EPS | ₹4.07 | ₹4.74 | -14.14% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 434.772 crores during the period ended December 31, 2021 as compared to Rs.210.740 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.22.539 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.21.601 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.4.07 for the period ended December 31, 2021 as compared to Rs.4.11 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 434.772 crs | ₹210.740 crs | 106.31% |
| Net Profit | ₹22.539 crs | ₹21.601 crs | 4.34% |
| EPS | ₹4.07 | ₹4.11 | -0.97% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.1057.431 crores during the 9 Months period ended December 31, 2021 as compared to Rs.497.430 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.73.290 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.57.793 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.13.29 for the 9 Months period ended December 31, 2021 as compared to Rs.11.12 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹1057.431 crs | ₹497.430 crs | 112.58% |
| Net Profit | ₹73.290 crs | ₹57.793 crs | 26.81% |
| EPS | ₹13.29 | ₹11.12 | 19.51% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 1059.95 as compared to the previous close of Rs. 1042.95. The total number of shares traded during the day was 13610 in over 1840 trades.
The stock hit an intraday high of Rs. 1095.35 and intraday low of 1050.80. The net turnover during the day was Rs. 14500443.00.
